Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

RIBAVIRIN vs VALGANCICLOVIR: Which Drug Is Safer?

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

RIBAVIRIN vs VALGANCICLOVIR: Safety Overview

Metric RIBAVIRIN VALGANCICLOVIR
Total FAERS Reports 43,397 7,913
Deaths Reported 2,494 1,274
Death Rate 5.7% 16.1%
Hospitalizations 8,495 3,092
Average Patient Age 55.7 yrs 48.8 yrs
% Female Patients 44.3% 41.2%
FDA Approval Date Apr 18, 2008 Apr 11, 2023
Manufacturer Aurobindo Pharma Limited NorthStar RxLLC
Route ORAL ORAL
Marketing Status Discontinued Prescription